RecruitingPhase 2NCT07235293
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Sponsor: Kahr Bio Australia Pty Ltd
Texas City, TX · +5 more sites
1 recruiting colorectal cancer studies with a site in Texas City, TX.
Sponsor: Kahr Bio Australia Pty Ltd
Texas City, TX · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.